Matthew Lewis, MD
Family Medicine · Aurora, CONPI 1790751360
Payments from drug & device makers
Across 1,219 payments — averaging $787.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$411K
- Novo Nordisk AS$300K
- Regeneron$156K
- AstraZeneca$31K
- Astrazeneca UK Limited$24K
- Amgen$24K
- plus $13K from 8 others
Across 2 payments — averaging $17,514 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$35K
What the payments were for
- Food & beverage$319100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 15 | $410,892 |
| Novo Nordisk AS | 1,115 | $300,120 |
| Regeneron | 44 | $156,178 |
| AstraZeneca | 7 | $31,360 |
| Astrazeneca UK Limited | 2 | $24,409 |
| Amgen(2 entities) | 3 | $23,523 |
| Kowa Research Institute, Inc. | 15 | $11,903 |
| Sanofi-aventis U.S. LLC | 1 | $1,000 |
| Novo Nordisk | 8 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $50 |
| AbbVie | 2 | $35 |
| Boehringer Ingelheim | 2 | $35 |
| Merck | 2 | $34 |
| Pfizer | 2 | $27 |
How this compares
$959,691 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $17,682 |
| EliquisApixaban | 14 | $12,787 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $12,502 |
| Atorvastatin Calcium | 225 | $2,091 |
| Omeprazole | 53 | $1,568 |
| Levothyroxine Sodium | 166 | $1,213 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $902 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $872 |
| Gabapentin | 22 | $630 |
| Tamsulosin Hcl | 73 | $615 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $577 |
| Bupropion Hcl SrBupropion Hcl | 22 | $522 |
| Lisinopril | 90 | $519 |
| Amlodipine Besylate | 75 | $465 |
| Escitalopram Oxalate | 46 | $441 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $127 | $17,68215 claims |
| PfizerEliquis | $27 | $12,78714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Aurora
- Timothy ColanderAurora$3.1M
- Tamara OserAurora$288K
- Sean OserAurora$248K
- Sarah DavisAurora$26K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Mia ScottDenver$993K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.